270 related articles for article (PubMed ID: 28277892)
1. Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.
Youngren-Ortiz SR; Hill DB; Hoffmann PR; Morris KR; Barrett EG; Forest MG; Chougule MB
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):299-321. PubMed ID: 28277892
[TBL] [Abstract][Full Text] [Related]
2. Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity.
Pápay ZE; Kósa A; Böddi B; Merchant Z; Saleem IY; Zariwala MG; Klebovich I; Somavarapu S; Antal I
J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):274-288. PubMed ID: 28282259
[TBL] [Abstract][Full Text] [Related]
3. Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy.
Esim O; Ozkan CK; Sarper M; Savaser A; Ozkan Y
Curr Drug Deliv; 2020; 17(7):622-628. PubMed ID: 32394837
[TBL] [Abstract][Full Text] [Related]
4. Molecularly targeted gemcitabine-loaded nanoparticulate system towards the treatment of EGFR overexpressing lung cancer.
Wang XB; Zhou HY
Biomed Pharmacother; 2015 Mar; 70():123-8. PubMed ID: 25776490
[TBL] [Abstract][Full Text] [Related]
5. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
Alibolandi M; Ramezani M; Abnous K; Hadizadeh F
J Pharm Sci; 2016 May; 105(5):1741-1750. PubMed ID: 27039356
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo.
Yalcin TE; Ilbasmis-Tamer S; Takka S
Int J Pharm; 2020 Apr; 580():119246. PubMed ID: 32205141
[TBL] [Abstract][Full Text] [Related]
7. Optimization of nanoemulsion containing gemcitabine and evaluation of its cytotoxicity towards human fetal lung fibroblast (MRC5) and human lung carcinoma (A549) cells.
Wahgiman NA; Salim N; Abdul Rahman MB; Ashari SE
Int J Nanomedicine; 2019; 14():7323-7338. PubMed ID: 31686809
[TBL] [Abstract][Full Text] [Related]
8. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.
Zhang R; Ru Y; Gao Y; Li J; Mao S
Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713
[TBL] [Abstract][Full Text] [Related]
9. Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)-development and in-vitro efficacy.
Elbatanony RS; Parvathaneni V; Kulkarni NS; Shukla SK; Chauhan G; Kunda NK; Gupta V
Drug Deliv Transl Res; 2021 Jun; 11(3):927-943. PubMed ID: 32557351
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.
Wang F; Wang Y; Ma Q; Cao Y; Yu B
Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196
[TBL] [Abstract][Full Text] [Related]
11. Controlled drug release from polyelectrolyte-drug conjugate nanoparticles.
Catarata R; Azim N; Bhattacharya S; Zhai L
J Mater Chem B; 2020 Apr; 8(14):2887-2894. PubMed ID: 32191246
[TBL] [Abstract][Full Text] [Related]
12. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation.
Karavana SY; Şenyiğit ZA; Çalışkan Ç; Sevin G; Özdemir Dİ; Erzurumlu Y; Şen S; Baloğlu E
Drug Des Devel Ther; 2018; 12():1959-1975. PubMed ID: 29997433
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine.
Dubey RD; Alam N; Saneja A; Khare V; Kumar A; Vaidh S; Mahajan G; Sharma PR; Singh SK; Mondhe DM; Gupta PN
Int J Pharm; 2015 Aug; 492(1-2):80-91. PubMed ID: 26165611
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer.
Shukla SK; Kulkarni NS; Farrales P; Kanabar DD; Parvathaneni V; Kunda NK; Muth A; Gupta V
Pharm Res; 2020 Mar; 37(3):67. PubMed ID: 32166411
[TBL] [Abstract][Full Text] [Related]
16. High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies.
Meenach SA; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
AAPS PharmSciTech; 2014 Dec; 15(6):1574-87. PubMed ID: 25139763
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo].
Tang CH; Liu XQ; Yang SF; Zhu B; Gao HJ
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):808-12. PubMed ID: 19173823
[TBL] [Abstract][Full Text] [Related]
18. Formulation and Pharmacokinetics of HSA-core and PLGA-shell Nanoparticles for Delivering Gemcitabine.
Wang X; Liang Y; Fei S; He H; Zhang Y; Yin T; Tang X
AAPS PharmSciTech; 2018 Feb; 19(2):812-819. PubMed ID: 29019099
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.
Tang Z; Feng W; Yang Y; Wang Q
Drug Des Devel Ther; 2019; 13():3281-3290. PubMed ID: 31571830
[TBL] [Abstract][Full Text] [Related]
20. Encapsulation of gemcitabine in RGD-modified nanoliposomes improves breast cancer inhibitory activity.
Cai W; Geng C; Jiang L; Sun J; Chen B; Zhou Y; Yang B; Lu H
Pharm Dev Technol; 2020 Jun; 25(5):640-648. PubMed ID: 32028816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]